Regulator of calcineurin 1 gene transcription is regulated by nuclear factor-kappaB

Current Alzheimer Research

Volumn 11, Issue 2, 2014, Pages 156-164

  Zheng, Lanlan ^a   Liu, Heng ^a   Wang, Pin ^a   Song, Weihong ^b   Sun, Xiulian ^a  

^a SHANDONG UNIVERSITY   (China)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Gene transcription; Negative feed back loop; Nuclear factor kappaB; RCAN

Indexed keywords

CALCINEURIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR NFAT; MUSCLE PROTEIN; RCAN1 PROTEIN, HUMAN; SIGNAL PEPTIDE;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL FUNCTION; CELL STRAIN HEK293; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EMBRYO; GEL MOBILITY SHIFT ASSAY; GENE; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GLIA CELL; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; NUCLEAR FACTOR KAPPA B RESPONSIVE ELEMENT; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN STRUCTURE; REGULATOR OF CALCINEURIN 1 GENE; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; DRUG EFFECTS; GENETICS; HEK293 CELL LINE; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; HEK293 CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MUSCLE PROTEINS; NF-KAPPA B; TRANSCRIPTION, GENETIC;

EID: 84897422685     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/1567205010666131212114907     Document Type: Article

References (43)

1. Fuentes JJ, Pritchard MA, Planas AM, Bosch A, Ferrer I, Estivill X. A new human gene from the Down syndrome critical region encodes a proline-rich protein highly expressed in fetal brain and heart. Hum Mol Genet 4(10): 1935-44 (1995).
2. Baek KH, Zaslavsky A, Lynch RC, Britt C, Okada Y, Siarey RJ, et al. Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1. Nature 459(7250): 1126-30 (2009).
3. Arron JR, Winslow MM, Polleri A, Chang CP, Wu H, Gao X, et al. NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21. Nature 441(7093): 595-600 (2006).
4. Chan B, Greenan G, McKeon F, Ellenberger T. Identification of a peptide fragment of DSCR1 that competitively inhibits calcineurin activity in vitro and in vivo. Proc Natl Acad Sci USA 102(37): 13075-80 (2005).
5. Rothermel BA, McKinsey TA, Vega RB, Nicol RL, Mammen P, Yang J, et al. Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo. Proc Natl Acad Sci USA 98(6): 3328-33 (2001).
6. Fuentes JJ, Genesca L, Kingsbury TJ, Cunningham KW, Perez-Riba M, Estivill X, et al. DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways. Hum Mol Genet 9(11): 1681-90 (2000).
7. Rothermel B, Vega RB, Yang J, Wu H, Bassel-Duby R, Williams RS. A protein encoded within the Down syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling. J Biol Chem 275(12): 8719-25 (2000).
8. van Rooij E, Doevendans PA, Crijns HJ, Heeneman S, Lips DJ, van Bilsen M, et al. MCIP1 overexpression suppresses left ventricular remodeling and sustains cardiac function after myocardial infarction. Circ Res 94(3): e18-26 (2004).
9. Stathatos N, Bourdeau I, Espinosa AV, Saji M, Vasko VV, Burman KD, et al. KiSS-1/G protein-coupled receptor 54 metastasis suppressor pathway increases myocyte-enriched calcineurin interacting protein 1 expression and chronically inhibits calcineurin activity. J Clin Endocrinol Metab 90(9): 5432-40 (2005).
10. Minami T, Horiuchi K, Miura M, Abid MR, Takabe W, Noguchi N, et al. Vascular endothelial growth factor-and thrombin-induced termination factor, Down syndrome critical region-1, attenuates endothelial cell proliferation and angiogenesis. J Biol Chem 279(48): 50537-54 (2004).
11. Abbasi S, Lee JD, Su B, Chen X, Alcon JL, Yang J, et al. Protein kinase-mediated regulation of calcineurin through the phosphorylation of modulatory calcineurin-interacting protein 1. J Biol Chem 281(12): 7717-26 (2006).
12. Abbasi S, Su B, Kellems RE, Yang J, Xia Y. The essential role of MEKK3 signaling in angiotensin II-induced calcineurin/nuclear factor of activated T-cells activation. J Biol Chem 280(44): 36737-46 (2005).
13. Hilioti Z, Gallagher DA, Low-Nam ST, Ramaswamy P, Gajer P, Kingsbury TJ, et al. GSK-3 kinases enhance calcineurin signaling by phosphorylation of RCNs. Genes Dev 18(1): 35-47 (2004).
14. Vega RB, Yang J, Rothermel BA, Bassel-Duby R, Williams RS. Multiple domains of MCIP1 contribute to inhibition of calcineurin activity. J Biol Chem 277(33): 30401-7 (2002).
15. Genesca L, Aubareda A, Fuentes JJ, Estivill X, De La Luna S, Perez-Riba M. Phosphorylation of calcipressin 1 increases its ability to inhibit calcineurin and decreases calcipressin half-life. Biochem J 374(Pt 2): 567-75 (2003).
16. Lin HY, Michtalik HJ, Zhang S, Andersen TT, Van Riper DA, Davies KK, et al. Oxidative and calcium stress regulate DSCR1 (Adapt78/MCIP1) protein. Free Radic Biol Med 35(5): 528-39 (2003).
17. Lee EJ, Seo SR, Um JW, Park J, Oh Y, Chung KC. NF-kappaBinducing kinase phosphorylates and blocks the degradation of Down syndrome candidate region 1. J Biol Chem 283(6): 3392-400 (2008).
18. Liu Q, Busby JC, Molkentin JD. Interaction between TAK1-TAB1-TAB2 and RCAN1-calcineurin defines a signalling nodal control point. Nat Cell Biol 11(2): 154-61 (2009).
19. Liu H, Wang P, Song W, Sun X. Degradation of regulator of calcineurin 1 (RCAN1) is mediated by both chaperone-mediated autophagy and ubiquitin proteasome pathways. FASEB J 23(10): 3383-92 (2009).
20. Sun X, Wu Y, Chen B, Zhang Z, Zhou W, Tong Y, et al. Regulator of calcineurin 1 (RCAN1) facilitates neuronal apoptosis through caspase-3 activation. J Biol Chem 286(11): 9049-62 (2011).
21. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS, Jr. NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281(5383): 1680-3 (1998).
22. Sethi G, Sung B, Aggarwal BB. Nuclear factor-kappaB activation: from bench to bedside. Exp Biol Med (Maywood) 233(1): 21-31(2008).
23. Baldwin AS, Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 14: 649-83.(1996).
24. Baeuerle PA, Baltimore D. I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science 242(4878): 540-6 (1988).
25. Baeuerle PA, Henkel T. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 12: 141-79 (1994).
26. Baldwin AS, Jr. review-The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 14: 649-83 (1996).
27. Alkalay I, Yaron A, Hatzubai A, Orian A, Ciechanover A, Ben-Neriah Y. Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitinproteasome pathway. Proc Natl Acad Sci USA 92(23): 10599-603 (1995).
28. Fuentes JJ, Pritchard MA, Estivill X. Genomic organization, alternative splicing, and expression patterns of the DSCR1 (Down syndrome candidate region 1) gene. Genomics 44(3): 358-61 (1997).
29. Yang J, Rothermel B, Vega RB, Frey N, McKinsey TA, Olson EN, et al. Independent signals control expression of the calcineurin inhibitory proteins MCIP1 and MCIP2 in striated muscles. Circ Res 87(12): E61-8 (2000).
30. Sun X, He G, Qing H, Zhou W, Dobie F, Cai F, et al. Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression. Proc Natl Acad Sci USA 103(49): 18727-32 (2006).
31. Sun X, Wang Y, Qing H, Christensen MA, Liu Y, Zhou W, et al. Distinct transcriptional regulation and function of the human BACE2 and BACE1 genes. FASEB J 19(7): 739-49 (2005).
32. Lu M, Zheng L, Han B, Wang L, Wang P, Liu H, et al. REST regulates DYRK1A transcription in a negative feedback loop. J Biol Chem 286(12): 10755-63 (2011).
33. Cano E, Canellada A, Minami T, Iglesias T, Redondo JM. Depolarization of neural cells induces transcription of the Down syndrome critical region 1 isoform 4 via a calcineurin/nuclear factor of activated T cells-dependent pathway. J Biol Chem 280(33): 29435-43 (2005).
34. de la Fuente V, Freudenthal R, Romano A. Reconsolidation or extinction: transcription factor switch in the determination of memory course after retrieval. J Neurosci 31(15): 5562-73 (2011).
35. Quintana A, Griesemer D, Schwarz EC, Hoth M. Calciumdependent activation of T-lymphocytes. Pflugers Archiv: Eur J Physiol 450(1): 1-12 (2005).
36. Mitchell AN, Jayakumar L, Koleilat I, Qian J, Sheehan C, Bhoiwala D, et al. Brain expression of the calcineurin inhibitor RCAN1 (Adapt78). Arch Biochem Biophys 467(2): 185-92 (2007).
37. Abdul HM, Sama MA, Furman JL, Mathis DM, Beckett TL, Weidner AM, et al. Cognitive decline in Alzheimer's disease is associated with selective changes in calcineurin/NFAT signaling. J Neurosci 29(41): 12957-69 (2009).
38. Swardfager W, Lanctot K, Rothenburg L, Wong A, Cappell J, Herrmann N. A meta-analysis of cytokines in Alzheimer's disease. Biol Psychiatry 68(10): 930-41 (2010).
39. Kaltschmidt B, Uherek M, Volk B, Baeuerle PA, Kaltschmidt C. Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc Natl Acad Sci USA 94(6): 2642-7 (1997).
40. Sambamurti K, Kinsey R, Maloney B, Ge YW, Lahiri DK. Gene structure and organization of the human beta-secretase (BACE) promoter. Faseb J 18(9): 1034-6 (2004).
41. Chami L, Buggia-Prevot V, Duplan E, Delprete D, Chami M, Peyron JF, et al. Nuclear factor-kappaB regulates betaAPP and beta-and gamma-secretases differently at physiological and supraphysiological Abeta concentrations. J Biol Chem 287(29): 24573-84 (2012).
42. Ly PT, Wu Y, Zou H, Wang R, Zhou W, Kinoshita A, et al. Inhibition of GSK3beta-mediated BACE1 expression reduces Alzheimer-associated phenotypes. J Clin Invest 123(1): 224-35 (2013).
43. Chen CH, Zhou W, Liu S, Deng Y, Cai F, Tone M, et al. Increased NF-kappaB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease. Int J Neuropsychopharmacol 15(01): 77-90 (2012).